VANGUARD GROUP INC

Holdings History for Aldeyra Therapeutics, Inc. - COM (ALDX)

Symbol: ALDX on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$20.3M	3.76M	+18,233	+0.49%	$5.39	Q3 2024
6/30/2024	0%	0%	$12.4M	3.74M	-126,693	-3.27%	$3.31	Q2 2024
3/31/2024	0%	0%	$12.7M	3.87M	-58,518	-1.49%	$3.27	Q1 2024
12/31/2023	0%	+0%	$13.8M	3.93M	+740,177	+23.2%	$3.51	Q4 2023
9/30/2023	0%	+0%	$21.3M	3.19M	+7,226	+0.23%	$6.68	Q3 2023
6/30/2023	0%	+0%	$26.7M	3.18M	+681,033	+27.3%	$8.39	Q2 2023
3/31/2023	0%	+0%	$24.8M	2.5M	+6,892	+0.28%	$9.93	Q1 2023
12/31/2022	0%	0%	$17.3M	2.49M	-23,615	-0.94%	$6.96	Q4 2022
9/30/2022	0%	+0%	$13.4M	2.52M	+79,126	+3.25%	$5.34	Q3 2022
6/30/2022	0%	0%	$9.72M	2.44M	-524,877	-17.7%	$3.99	Q2 2022
3/31/2022	0%	+0%	$13.2M	2.96M	+147,711	+5.25%	$4.45	Q1 2022
12/31/2021	0%	+0%	$11.3M	2.81M	+86,528	+3.17%	$4.00	Q4 2021
9/30/2021	0%	+0%	$23.9M	2.73M	+30,946	+1.15%	$8.78	Q3 2021
6/30/2021	0%	+0%	$30.6M	2.7M	+643,955	+31.4%	$11.33	Q2 2021
3/31/2021	0%	+0%	$24.4M	2.05M	+436,721	+27%	$11.88	Q1 2021
12/31/2020			$2K	231			$8.66^*	Q4 2020
12/31/2020	0%	0%	$11.1M	1.62M	-35,984	-2.18%	$6.86	Q4 2020
9/30/2020	0%	+0%	$12.2M	1.65M	+618,879	+59.9%	$7.41	Q3 2020
6/30/2020	0%	0%	$4.31M	1.03M	-93,671	-8.31%	$4.17	Q2 2020
3/31/2020	0%		$2.78M	1.13M	+1,218	+0.11%	$2.47	Q1 2020
12/31/2019	0%	0%	$6.54M	1.13M	-3,285	-0.29%	$5.81	Q4 2019
9/30/2019	0%	+0%	$5.95M	1.13M	+16,673	+1.5%	$5.27	Q3 2019
6/30/2019	0%	+0%	$6.67M	1.11M	+42,869	+4.01%	$6.00	Q2 2019
3/31/2019	0%	0%	$9.65M	1.07M	-30,545	-2.78%	$9.03	Q1 2019
12/31/2018	0%	+0%	$9.13M	1.1M	+151,744	+16%	$8.30	Q4 2018
9/30/2018	0%	+0%	$13.1M	948K	+193,707	+25.7%	$13.80	Q3 2018
6/30/2018	0%	+0%	$6M	754K	+56,535	+8.1%	$7.95	Q2 2018
3/31/2018	0%		$5.23M	698K	-900	-0.13%	$7.50	Q1 2018
12/31/2017	0%	+0%	$4.75M	699K	+227,503	+48.3%	$6.80	Q4 2017
9/30/2017	0%	+0%	$3.39M	471K	+166,398	+54.6%	$7.20	Q3 2017
6/30/2017	0%	+0%	$1.43M	305K	+9,407	+3.19%	$4.70	Q2 2017
3/31/2017	0%	+0%	$1.48M	295K	+149,754	+103%	$5.00	Q1 2017
12/31/2016	0%	+0%	$779K	145K	+12,586	+9.47%	$5.35	Q4 2016
9/30/2016	0%	+0%	$1.04M	133K	+7,761	+6.2%	$7.85	Q3 2016
6/30/2016	0%	+0%	$712K	125K	+3,718	+3.06%	$5.69	Q2 2016
3/31/2016	0%	+0%	$508K	121K	+3,067	+2.59%	$4.18	Q1 2016
12/31/2015	0%	+0%	$802K	118K	+11,070	+10.3%	$6.78	Q4 2015
9/30/2015	0%	+0%	$626K	107K	+3,800	+3.67%	$5.84	Q3 2015
6/30/2015	0%	+0%	$802K	103K	+103,470	NEW	$7.75	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.